The effects of miR-375 expression in NSCLC via the L4-3-3ζ/ERK/MYC pathway

来源 :肿瘤学与转化医学:英文版 | 被引量 : 0次 | 上传用户:sargelee
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
其他文献
Objective Epidermal growth factor receptor(EGFR) and vascular endothelial growth factor(VEGF) inhibitors are two targeted therapies for metastatic colorectal ca
Objective This study aimed to compare and analyze the clinical efficacy and safety of late-course and simultaneous integrated dose-increasing intensity-modulate
Objective The aim of this study was to evaluate the safety and efficacy of multi-kinase inhibitor plus endostar treatment in patients with metastatic renal cell
Objective G719 X is the most frequently seen uncommon mutation of the epidermal growth factor receptor(EGFR) gene, which is a point mutation at exon 18 with thr
Objective The aim of the study was to study the expression and clinical significance of MCM5 and P16 in cervical intraepithelial neoplasia(CIN)and cervical canc